Innovative Trial Offers Hope for Pancreatic Cancer Patients
The rise in pancreatic cancer cases among young women underscores the need for effective treatments. Theriva Biologics' innovative trial with oncolytic virus therapies offers hope for improving outcomes and reducing negative side effects in pancreatic cancer patients.
The disproportionate rise in pancreatic cancer cases among young women highlights the urgent need for safe and effective treatments. Theriva Biologics' innovative approach with oncolytic virus therapies offers hope for improving outcomes and reducing negative side effects for pancreatic cancer patients.
